FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology. Described is a novel bispecific antibody construct, having a different specificity for each binding site and consisting of two copies of a polypeptide of one heavy chain and a first light chain and a second light chain, where first and second light chains are different. One of light chains contains a Kappa constant domain, and other contains a Lambda constant domain. Invention also describes methods of producing such construct. Described are methods of extracting antibodies of different specificity, but having a common heavy chain. Antibody according to invention enables to combine two targets simultaneously.
EFFECT: invention enables to minimise risk of immunogenicity.
36 cl, 22 dwg, 5 tbl, 15 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS FOR PRODUCTION OF MULTI-SPECIFIC AND MULTIVALENT ANTIBODIES | 2011 |
|
RU2780412C2 |
ANTI-CD47 ANTIBODIES AND METHODS FOR USE THEREOF | 2013 |
|
RU2693078C2 |
POLYSPECIFIC ANTIBODIES CONTAINING ANTIBODY OF FULL LENGTH AND ONE-CHAIN FRAGMENTS FAB | 2010 |
|
RU2598248C2 |
MULTISPECIFIC ANTIBODY CONSTRUCTS | 2015 |
|
RU2710730C2 |
HEAVY CHAIN-ONLY ANTIBODIES THAT BIND TO CD19 | 2019 |
|
RU2824170C2 |
OBTAINING MULTISPECIFIC MIXTURES OF ANTIBODIES AND METHODS OF USE THEREOF | 2018 |
|
RU2815826C2 |
ANTIBODIES AGAINST A2 TENASTIN-C AND METHODS FOR USE THEREOF | 2011 |
|
RU2584597C2 |
EASILY EXTRACTABLE BIOSPECIFIC ANTIBODIES WITH NATURAL IMMUNOGLOBULIN FORMAT | 2014 |
|
RU2569157C2 |
READILY ISOLATED BISPECIFIC ANTIBODIES WITH NATIVE IMMUNOGLOBULIN FORMAT | 2010 |
|
RU2522002C2 |
EASILY-ISOLATED BISPECIFIC ANTIBODIES WITH NATURAL IMMUNOGLOBULIN FORMAT | 2015 |
|
RU2647758C2 |
Authors
Dates
2017-01-23—Published
2011-08-16—Filed